DAR-AL-HANDASAH
12.8.2024 16:52:32 CEST | Business Wire | Press release
Ethiopian Airlines Group has announced plans to build Africa’s largest airport in Abusera – a critical element of Ethiopian’s 15-year strategic plan to become one of the most competitive aviation groups in the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240812311709/en/
Ethiopian Airlines Group CEO Mesfin Tasew and Dar’s Director of Operations in Ethiopia Tariq Al-Qanni sign consultancy contract for new Abusera International Airport. (Photo: AETOSWire)
The airport’s location allows for progressive growth, empowering the airline to meet the International Air Transport Association’s forecasts of more than 200% growth over the next decade – growing beyond Bole International Airport, which offers no possibilities for significant expansion. Abusera’s lower altitude will elevate aircraft take-off performance, while an express rail link to Addis Ababa facilitates connectivity.
In its first phase scheduled for 2029, the airport will have capacity for 60 million passengers annually – almost three times Africa’s current busiest airport – creating thousands of jobs to serve Ethiopian’s expanding customer base and fleet. Ultimately, the airport will serve 110 million passengers annually – four times the capacity of Bole International Airport.
Ethiopian’s CEO Mesfin Tasew stated: “With its exceptional capacity and world-class facilities, this new airport promises to elevate African aviation.”
To deliver this transformational new project, Ethiopian Airlines awarded a consultancy contract to a consortium led by Dar Al-Handasah Consultants (Shair and Partners), with Zaha Hadid Architects (ZHA), Pascall+Watson Architects, Landrum&Brown, and TY Lin.
Dar, TY Lin, and Landrum&Brown belong to Sidara, a global collaborative that ranks 1st in aviation (Engineering News Record 2023). ZHA brings award-winning design capabilities and a global track-record of acclaimed airport projects, while Pascall+Watson Architects has successfully completed over 2,000 aviation projects across 70 airports.
Collectively, these companies will cover technical advisory, engineering, project management, and construction supervision services for 600,000 m2 of passenger facilities, 126,000 m2 of airline support facilities, two Code 4E parallel runways along with associated airfield infrastructure, and other major airport facilities and infrastructure.
About Ethiopian Airlines Group
Ethiopian is one of the fastest-growing airlines globally and the largest in Africa. Building on a highly successful 78-year track record, Ethiopian operates Africa’s most modern fleet to more than 150 destinations across five continents.
https://www.ethiopianairlines.com/et
About Dar
Dar provides design, planning, engineering, and management services for buildings, cities, transportation, and infrastructure projects.
About Zaha Hadid Architects (ZHA)
Founded 45 years ago in London, ZHA offers architecture, design, and planning services worldwide.
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240812311709/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NTT DOCOMO BUSINESS and Chile’s State-owned Copper Company CODELCO Launch a Study and Proof of Concept Aimed at Improving the Efficiency of Remote Copper Mine Operations Using IOWN® APN6.8.2026 06:30:00 CEST | Press release
NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation) has launched a study and proof of concept jointly with Corporación Nacional del Cobre de Chile (CODELCO) to progress remote operations at CODELCO’s copper mines using an IOWN® All-Photonics Network (APN).1 This initiative is part of a research project commissioned by Japan’s Ministry of Internal Affairs and Communications.2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806845222/en/ Conceptual Diagram of the Demonstration To address operational challenges faced by CODELCO’s copper mines, the initiative will connect a copper mine and a remote operations center—approximately 1,500 km apart—via an IOWN APN. It will assess the feasibility of remotely operating heavy machinery using high-capacity, low-latency communication links, enhancing monitoring operations through high-definition video, and implementing a remote operations model. 1. Background Chile is o
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom